This novel PARIS transgenic mice successfully recapitulate key PD pathologies including selective, robust, and progressive dopaminergic neuron loss, dopamine depletion in the striatum, mitochondrial dysfunction, α-synuclein aggregation, and neuroinflammation. The gene discussed is SNCA; the disease is Parkinson disease.